12500 L
Retatrutide is an investigational triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways. Clinical trials have demonstrated promising effects on weight reduction and metabolic markers.
German 
English 
French 
Greek 
Italian 
Spanish 
Albanian